Hershey says it will shift back to classic recipe for all Reese's products after criticism

25%: Hershey will increase R&D funding by 25% next year and is reverting all Reese’s products to classic milk and dark chocolate recipes, with certain lower-chocolate coated items slated to return to classic recipes by 2027 after public criticism. The company also plans to transition to natural colors and enhance Kit-Kat’s recipe to be creamier. The changes respond to brand/reputation pressure (a public letter from the founder's grandson) and prior efforts to offset high cocoa prices; expected financial impact is modest and concentrated in affected SKUs.

Analysis

Hershey’s decision to reverse product downgrades is a de facto valuation of brand equity over short-term COGS savings; that signal should compress the volatility premium for HSY relative to peers because it reduces tail reputational risk. The 2027 implementation horizon buys the company time to re-source ingredients and smooth margin impact, but it also creates a multi-quarter window where R&D and ingredient purchases change cost dynamics and invite competitor marketing countermeasures.

Operationally, reverting to higher-chocolate coatings and natural colors shifts demand back toward cocoa and specific dairy/color suppliers; while Hershey alone won’t move global cocoa balances, a broad industry follow-through would raise near-term cocoa tightness — cocoa has shown +/- ~30% realized moves in 12-month windows historically, so hedging/forward procurement matters. The announced +25% R&D budget is an explicit opex load: if management uses it to behind-the-scenes product improvements and gradual price/promo recovery, margins can normalize, but failure to pass-through costs or botched reformulations would compress margins for 1–3 years.

Key risks: (1) execution risk—sourcing natural colors at scale and reformulating without increasing breakage/short-dated SKUs; (2) demand risk—consumers may not reward the return with higher willingness-to-pay; (3) commodity risk—a cocoa/dairy price shock could blow out input costs before pricing catches up. Watch near-term catalysts (quarterly R&D spend cadence, pilot SKU reviews, competitor responses) and newsflow that would reverse the thesis (rapid cocoa price declines, wholesale demand softness, or a failed product relaunch).

Key Decisions for Investors

• Long HSY equity (12–24 months): overweight HSY vs staples basket. Rationale: de-risked brand, optionality from recipe premium and R&D-led product improvement. Target +20–30% total return if management recovers 50–75% of incremental ingredient cost via mix/price; downside ~15% in a commodity shock. Size 3–5% NAV.
• Pair trade — Long HSY / Short MDLZ (12–18 months): HSY should capture more premium margin from brand authenticity while MDLZ is less positioned to credibly trade up. Aim for 1.5–2.0x notional HSY exposure to short MDLZ, stop-loss if spread moves >10% against position.
• Options: HSY Jan 2028 call spread (buy OTM call / sell higher strike call) to express constructive view into the 2027 implementation window. Cost-limited trade with asymmetric upside if market re-rates earnings power; use 2:1 reward-to-cost target and cap premium outlay to <1% NAV.
• Commodity hedge/trade — Long cocoa exposure (6–12 months) via NIB or front-month cocoa futures: modest long to front-run increased chocolate content across SKUs. Keep position small (0.5–1% NAV) and hedge with short exposure or trailing stops because cocoa can mean-revert quickly.
• Risk-management: if initiating long HSY, buy short-dated protective puts (3–6 months) to protect against headline-driven sell-offs; alternatively size position with 60–70% funded via covered calls after entry to harvest premium while waiting for execution catalysts.